Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07324070 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression

Study acronym: RMTSECT2
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The RTMSECT2 study was design to compare the application of electroconvulsive therapy augmented by transcranial magnetic stimulation. Subject will be compared both within groups and in group using psychometric scales and different deliver energy
Trial Details
NCT Number NCT07324070
Lead Sponsor Charles University, Czech Republic
Conditions
(from sponsor)		 Major Depressive Disorder (MDD), Treatment Resistant Depression (TRD)
Related terms Depressive Disorder, Treatment-Resistant, Major Depressive Disorder
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov